863483-01-6

Basic information

• Product Name: 5-tert-butoxycarbonylamino-2,2-dimethyl-[1,3]dioxane-5-carboxylic acid 2-(4-iodo-phenyl)-2-oxo-ethyl ester
• Synonyms: 5-tert-butoxycarbonylamino-2,2-dimethyl-[1,3]dioxane-5-carboxylic acid 2-(4-iodo-phenyl)-2-oxo-ethyl ester
• CAS NO: 863483-01-6
• Molecular Weight: 519.333
• Mol File: 863483-01-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-tert-butoxycarbonylamino-2,2-dimethyl-[1,3]dioxane-5-carboxylic acid 2-(4-iodo-phenyl)-2-oxo-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-tert-butoxycarbonylamino-2,2-dimethyl-[1,3]dioxane-5-carboxylic acid 2-(4-iodo-phenyl)-2-oxo-ethyl ester(863483-01-6)
• EPA Substance Registry System: 5-tert-butoxycarbonylamino-2,2-dimethyl-[1,3]dioxane-5-carboxylic acid 2-(4-iodo-phenyl)-2-oxo-ethyl ester(863483-01-6)

Safety Data

• Hazardous Substances Data: 863483-01-6(Hazardous Substances Data)

Upstream product

• 364631-72-1 tert-butyl N-[5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-5-yl]carbamate 
• 364631-73-2 tert-butyl 5-formyl-2,2-dimethyl-1,3-dioxan-5-ylcarbamate 
• 13329-40-3 4-Iodoacetophenone 
• 53104-32-8 (5-amino-2,2-dimethyl-1,3-dioxan-5-yl)methanol 
• 654067-56-8 5-((tertbutoxycarbonyl)amino)-2,2-dimethyl-1,3-dioxane-5-carboxylic acid 
• 31827-94-8 2-bromo-1-(4-iodophenyl)ethanone 

Downstream Products

• 863483-02-7 {2,2-dimethyl-5-[5-(4-oct-1-ynyl-phenyl)-1H-imidazol-2-yl]-[1,3]dioxan-5-yl}-carbamic acid tert-butyl ester 
• 654067-58-0 {2,2-dimethyl-5-[5-(4-octyl-phenyl)-1H-imidazol-2-yl]-[1,3]dioxan-5-yl}-carbamic acid tert-butyl ester 
• 654067-57-9 {5-[5-(4-iodo-phenyl)-1H-imidazol-2-yl]-2,2-dimethyl-[1,3]dioxan-5-yl}-carbamic acid tert-butyl ester 

Relevant articles and documents

Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1- phosphate and FTY720: Discovery of potent S1P1 receptor agonists

The novel immunosuppressant FTY720 has been demonstrated to elicit immunomodulating effects via interaction with the G-protein coupled receptor S1P1. FTY720 induced agonism at the S1P3 receptor, however, has been shown to result in m